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Executive Summary 
During the last two decades, Nigeria’s Contraceptive Prevalence Rate (CPR) for modern methods 
remained at 10% (NPC and ICF International 2014), one of the lowest rates in sub-Saharan Africa. 
Following the renewed global commitments culminating in the 2012 London Summit on Family 
Planning with promises to reach an additional 120 million new users of quality modern 
contraceptives worldwide, Nigeria’s Federal Ministry of Health (FMoH) in collaboration with 
reproductive health (RH) stakeholders set an ambitious new target of raising Nigeria’s CPR to 36% by 
2018. One of the ways to accomplish this goal is by meeting the contraceptive needs of women in the 
immediate postpartum period and beyond. Currently, unmet need for contraception in the 
postpartum period is 65% as opposed to 16% for regular use (NPC and ICF International 2014). 
Consequently, attention is being focused on making proven and effective contraceptive methods 
more available and affordable for postpartum use by including in the methods newer technologies 
that are breastfeeding-friendly. The Progesterone Vaginal Ring (PVR) holds much promise as an 
effective family planning method specifically geared for breastfeeding women. For use beyond the 
postpartum period, an investigational long-acting Contraceptive Vaginal Ring (CVR) is currently being 
developed. As a prelude to introducing the rings in sub-Saharan Africa, the Population Council, with 
funding from the Bill and Melinda Gates Foundation (BMGF) and the United States Agency for 
International Development (USAID), conducted a “Willingness to Pay’ (WTP) study in Kenya, Nigeria, 
and Senegal. In order to better understand how the rings could be placed within an equity framework 
and achieve an optimized service environment, we ensured that both consumers’ and providers’ 
preferences, as well as procurers’ priorities, were factored into the introductory process. This 
informed the conduct of this “Willingness to Pay, Provide, and Procure” exercise in these three sub-
Saharan African countries. 
Key findings from the study in Nigeria include: 
 Prospective consumers, providers, and procurers expressed support and interest in 
contraceptive vaginal rings (CVRs). Frequently expressed opinions were that the PVR (and the 
one-year CVR) are a welcome development that would add value to the postpartum family 
planning landscape, widen contraceptive options for women, enhance child spacing, and 
prevent unintended pregnancies. 
 Consumers are willing to pay for the PVR irrespective of the sector where they access their 
contraceptive commodities. At a price point of US$1.70 (N300), more than 75% of 
consumers are willing to pay for the PVR in the public, private nonprofit, and commercial 
sectors. In the public sector, willingness to pay declines at prices over N300. However, in the 
private sector (nonprofit and commercial), a significant proportion of women are willing to 
purchase the PVR at higher prices.   
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 Although the price of the PVR is a determinant of consumer demand, respondents also 
indicated other factors such as the desire to avoid unintended pregnancy and the ability to 
use modern contraceptives as being important to their decision-making. The importance of 
wanting to avoid unwanted pregnancy is clearly reflected in the market as evidenced by the 
high median cost of emergency contraceptive (EC) pills (US$27) in the private sector.   
 Consumers were willing to pay for the one-year CVR as well. The analysis indicates a feasible 
price point of US$9 (N1,500) with a demonstrated willingness to pay across all three sectors.  
At this price, over 65% are willing to pay in the public sector and over 80% in the private 
nonprofit and commercial sectors.   
 The potential for innovative pricing mechanisms, especially for public-sector consumers, will 
need to be explored. The mechanism would leverage existing government subsidies so that 
consumers pay a small portion of the price with financing covering the rest.   
 Providers across all three sectors indicated the importance of including the PVR and the one-
year CVR in the method mix. Their responses also highlighted the importance of orientation 
and education of potential providers to ensure their successful integration when eventually 
registered.  
 The procurement, pricing, and quality assurance systems are robust in Nigeria. The PVR (and 
the one-year CVR), when introduced, could easily feed into the existing structures and obviate 
the need for establishing parallel procurement, pricing, and quality assurance systems for the 
PVR and the one-year CVR. 
In terms of utilization, the results generated will inform and guide next steps about product 
introduction. Specifically, the findings of this study will be integrated with results from a market 
segmentation exercise conducted earlier to develop a pricing model for the PVR. The price will reflect 
not only the cost of goods (COGS) and cost of product introduction (training, educational material, 
marketing and branding, demand creation) but also the benefits to the health system (e.g., limited 
need for infrastructure and equipment, potential for multiple service outlets and health cadres). The 
results will also be useful to refine PVR market segmentation and tailor specific strategies for product 
introduction, including innovative financing approaches. 
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Introduction 
During the last two decades, the contraceptive prevalence rate (CPR) for modern methods has 
remained at 10% in Nigeria (NPC and ICF International 2014), one of the lowest rates in sub-Saharan 
Africa. Following the renewed global commitments culminating in the 2012 London Summit on Family 
Planning,1 which aims at reaching an additional 120 million new users with quality modern 
contraceptive methods by the year 2020, the Federal Ministry of Health (FMoH) in collaboration with 
reproductive health stakeholders in Nigeria unveiled the Nigeria Family Planning Blueprint with an 
ambitious new target of raising the contraceptive prevalence rate to 36% by 2018.2 This scale-up 
plan will help avert 1.6 million unintended pregnancies, as well as 400,000 infant and 700,000 child 
deaths, by the year 2018 at an estimated cost of US$603 million. 
An integral part of this commitment involves meeting the contraceptive needs of women in the 
immediate postpartum period and beyond with the help of expanded social marketing services. 
Currently, the unmet need for contraception in the postpartum period is 65% as opposed to 16% for 
regular use (NPC and ICF International 2014). Consequently, attention is now being focused on 
making available and accessible proven effective contraceptives for postpartum use. Contraceptive 
Vaginal Rings (CVRs), as a new product category, hold a lot of potential as an effective family planning 
method for women throughout their reproductive health life cycle. As a self-initiated method that does 
not require daily action by the user or significant health system infrastructure for service delivery, 
vaginal rings can be a great addition to the existing method mix for modern contraception.  
The Progesterone Vaginal Ring (PVR) is designed exclusively for addressing the postpartum family 
planning needs of breastfeeding women. While the PVR is already being used by women in nine 
countries in Latin America, women in sub-Saharan Africa, where breastfeeding is almost universal, 
have no access to this technology. To expand access in this region, the Population Council, with 
funding from the Bill & Melinda Gates Foundation (BMGF) and the United States Agency for 
International Development (USAID), conducted various pre-introductory activities in sub-Saharan 
Africa where women practice prolonged lactation and also have a high unmet need for postpartum 
family planning of up to 65% in many countries (Sonalkar et al. 2013). The assessment of 
“Willingness to Pay” (WTP) for the PVR was conducted to understand economic factors that may 
determine its uptake and use. In the case of contraceptives, WTP informs about the value that 
people attach to the benefits of various contraceptives, especially their willingness and intentions 
to purchase these contraceptives at various hypothetical prices. The study provides new 
knowledge on the maximum amount of money that consumers are willing to spend for the PVR 
and a related ring, the one-year CVR, from various service sectors (public, private nonprofit, and 
private commercial). 
Currently, Nigerian women obtain their contraceptive methods from both the public and private 
sectors (nonprofit and commercial). A range of methods, including intrauterine contraceptive devices 
(IUDs), implants, injectables, surgical tubal occlusion, and vasectomy are available for postpartum 
use through Nigeria’s family planning policy. However, while contraceptive products are free in the 
public sector (with minimum allowable fees charged to cover for the costs of consumables), they are 
                                                                        
 
1 FP2020: http://progress.familyplanning2020.org/ 
2 Health Policy Project, Nigeria Family Planning Blueprint (Scale-Up Plan): http://www.healthpolicyproject.com/index.cfm?ID=topics-FP2020. 
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not free in the private sector, which provides 60% of contraceptive services in the country (NPC and 
ICF International 2014). Ever-increasing changes in the funding landscape have prompted 
governments to explore “total market” solutions. The Total Market Approach (TMA) identifies specific 
roles for the public and private sectors to meet the family planning needs of the population. 
Specifically, the TMA focuses on ensuring that free or subsidized contraceptives are available to the 
needy and poor, while social marketing channels and other private commercial sales of 
contraceptives cater to those who are able to pay. This approach can help ensure equity and 
sustainability of products and services over time and also manage funding shortfalls. Although 
contraceptive commodities are free of charge in the public sector, commodity stock-outs are frequent 
and so the private sector plays a dominant role in meeting women’s contraceptive needs. 
The Nigeria Family Planning Blueprint includes strategies on service delivery, supply-chain 
management, demand generation and behavior-change communications, and financing. By 
investigating consumers’ willingness to pay for the ring, providers’ willingness to provide, and 
procurers’ willingness to procure the ring in the three sectors that serve the total reproductive health 
market in Nigeria, this study can inform programmatic interventions to contribute to these strategies. 
A previously concluded market-segmentation exercise for vaginal rings provides us with the 
knowledge of the various customer segments we will be serving when we introduce vaginal rings into 
Nigeria’s family planning (FP) method mix. By matching different types of providers and services with 
their appropriate target segments, we can promote effective intersectoral coordination and help the 
Nigerian government better allocate resources to meet its FP2020 goals and beyond. In the PVR 
introduction pathway, this study offers a reliable way of making evidence-based pricing decisions for 
a new FP product and designing programs to achieve a total market solution for balancing the scales 
of sustainability and cost recovery. 
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Setting 
COUNTRY ECONOMIC CONTEXT 
Although Nigeria now has the largest economy in Africa based on its current GDP (Africa Progress 
Panel 2015), the poverty rate in the country is one of the highest in the region with up to 61% of the 
population living on less than US$1 per day (NBS 2012). Categorized as a lower-middle-income 
economy, Nigeria is driven almost entirely by its thriving petroleum sector, which is the twelfth largest 
in the world. More than 90% of foreign exchange earnings come from petroleum products, while the 
rest of the economy is mostly agrarian. The recent fall in the price of oil in the international market 
has implications for public expenditures on social welfare programs including health. Nigeria has 
been growing at 6–8% annually over the past decade but now needs to achieve even higher job-led 
growth rates to make a dent in poverty. A key challenge facing Nigeria is the diversification of its 
economy and the reduction of heavy reliance on oil, which makes the country vulnerable to 
commodity price volatility. However, Nigeria’s short-term economic outlook has improved in 2014 and 
growing government revenues indicate macroeconomic stability and positive growth prospects. 
Recent World Bank assessments highlight the decline in poverty levels; poverty is much lower in 
urban areas (12.6%) than in rural areas (44.9%).3 After a minor slump in 2012, GDP growth 
increased from 5.5% in 2013 to 6.3% in 2014. Inflation has remained on a downward trend since 
2011 with the Consumer Price Index (CPI) inflation rate falling within the 8% range. While the 
unemployment rate is about 10%4 and scarcity of jobs continues to be an economic problem, rapid 
urbanization leading to higher connectivity with larger markets is having a positive impact on the 
economy. 
As of 2014, the per capita household final consumption expenditure (the market value of all goods 
and services, including durable products such as cars, washing machines, and home computers 
purchased by households) in Nigeria is on an upward trend reaching US$6165 and the gross national 
income per capita remains stable at around US$2,970 (current US$). In 2013, expenditure on private 
health was 2.8 % of GDP, which includes direct household (out-of-pocket) spending, private 
insurance, and charitable donations by private corporations, increasing from 2.3% in 2012. Public 
health expenditure6 was 1.1% of GDP in 2013 and has remained at this level since 2011. Total 
health expenditure7 has risen steadily from 3.4% of GDP in 2012 to 3.9% in 2013.  
As Nigeria has a three-tier system of government (federal, state, and local) with different revenue 
bases, there is potential for program priorities to differ between the three levels of administration 
with implications for how social programs are planned and implemented. This may affect 
harmonization of social investment including procurement of reproductive health and family planning 
commodities especially for the public sector.  
                                                                        
 
3 World Bank: Nigeria Economic Report (www.worldbank.org). 
4 The internationally accepted ILO definition of unemployment includes members of the active labor population who are looking for work and are 
available for work, but who are not working, during a previous reference period (often one week). 
5 Data reported in constant 2005 US dollars. Source: World Bank national accounts data, and OECD national accounts data files. 
6 Public health expenditure consists of recurrent and capital spending from government (central and local) budgets, external borrowings and 
grants (including donations from international agencies and nongovernmental organizations), and social (or compulsory) health insurance funds. 
7 Total health expenditure is the sum of public and private health expenditure. It covers the provision of health services (preventive and curative), 
family planning activities, nutrition activities, and emergency aid designated for health, but does not include provision of water and sanitation. 
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COUNTRY FAMILY PLANNING FINANCING CONTEXT 
In Nigeria, family planning financing was entirely donor-driven until 2011 when the Federal 
Government of Nigeria committed to providing US$3 million annually from 2011 to 2015 for 
procurement of contraceptives for the public sector. Following the London summit in 2012, the 
Nigerian government made a further pledge of providing an additional US$8.3 million for the same 
reasons. The United Nations Population Fund (UNFPA) is the leading procurer of contraceptives for 
the public sector, while USAID and the United Kingdom Department for International Development 
(DfID) provide support for the private sector (Tien et al. 2009).  
Investments from other development partners play a supplementary role. For example, from 2009 to 
2015, BMGF invested in providing contraceptives (oral contraceptives, injectables, implants, 
intrauterine devices) and services in urban areas through its Urban Reproductive Health Initiative 
(URHI), which was recently renewed. URHI addresses challenges on the supply and demand side of 
contraceptive use. The Society for Family Health (SFH) and DKT International8 are the leading social 
franchising organizations that distribute reproductive health commodities in the private sector at 
subsidized prices, thus serving a market segment that has limited ability to pay for services/products. 
Available methods for postpartum women include injectables, condoms, progestin-only pills, and the 
lactational amenorrhea method (LAM), with LAM being the most commonly used during this period 
(Borda and Winfrey 2010). Data from the Nigeria DHS 2013 suggests that the major sources of 
modern contraceptive methods for women are private health facilities, which supply 60%, followed by 
public facilities at 29%.  
Within the public sector, all contraceptives are offered free of charge by policy, but commodity stock-
outs are a frequent problem. This, coupled with service-fees, limits the utility of this policy because 
methods are either not available or service fees are prohibitive. Consequently, a majority of users 
obtain their contraceptives from the private sector at open market prices. The median cost of modern 
contraceptives for women who paid for the last method they obtained ranged from about US$62 for 
surgical contraception to less than US$1 each for pills and male condoms (NPC and ICF Macro 
2009). The active role played by both the private and public sector in providing family planning 
services indicates the potential for utilizing a total market solution for PVR introduction. 
                                                                        
 
8 DKT International is a social marketing organization named after Deep K. Tyagi, Assistant Commissioner of Family Planning in charge of the 
public motivation and education aspects of India’s Family Planning Program. 
TABLE 1   Cost of living snapshot in Abuja, Nigeria 
Commodity Quantity Average Price (US$) 
Milk 1 gallon 6.7 
Bread 1 pound 1.4 
Eggs 1 dozen 2.0 
Onions 1 pound 1.1 
Beef 1 pound 2.1 
Gasoline 1 gallon 1.7 
Source: www.numbeo.com. 
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Study Objectives 
The objectives of this study are as follows:  
 Obtain a reliable estimate of consumers’ demand for the PVR in Nigeria by studying the effect 
of price on demand;   
 Assess the “Willingness to Provide” by family planning providers and “Willingness to Procure” 
by procurers; 
 Facilitate evidence-based pricing for the PVR in the three sectors of interest—public, private 
nonprofit, and private commercial; and 
 Explore respondents’ Willingness to Pay for future vaginal rings (including long-acting, 
reversible options for nonbreastfeeding women) to assess potential demand and to design 
access strategies. 
 
STUDY DESIGN AND METHODOLOGY 
A cross-sectional study was conducted in three countries in sub-Saharan Africa (Kenya, Nigeria, and 
Senegal). The study used a multidimensional and multisectoral approach, which examined the 
willingness to pay for the PVR in the three countries.  
Stakeholder-driven approach to WTP:  In this approach (see Figure 1), we identified three actors in 
the PVR WTP assessment landscape: potential consumers, providers, and procurers. We explored the 
three dimensions of WTP (Willingness to Pay, Willingness to Provide, and Willingness to Procure) by 
incorporating the voices of these three stakeholders in the data-collection tools.  
Sector-driven approach to WTP: Using the guiding principles of improved access, efficient use of 
public resources, and increased equity, we explored a potential total market model for the PVR by 
exploring the views and expectations of different sectors that serve the family planning customers— 
the public, private nonprofit, and private commercial sectors. 
A previously conducted market-segmentation exercise based on DHS data revealed three broad 
segments of potential PVR customers (Obare et al. 2014). Based on the analysis of the 
socioeconomic profiles of these segments, the first segment denoted as “Easy Switchers” (urban, 
educated women from rich households) presents the group with potentially the highest WTP, while 
the other two segments—“Remote First-Timers” (rural, poorly educated women from the poorest 
households) and “Growth Feeders” (young women with a future need for the PVR)—present potentially 
decreasing levels of WTP. By utilizing a stakeholder-driven multisectoral approach to assess users’ 
WTP, this study will help develop affordable yet competitive pricing strategies for the PVR. The aim of 
a TMA is to improve the performance of health systems by delivering the highest degree of 
effectiveness, equity, and efficiency with the help of coordinated activities across the three sources of 
supply. The study findings will help us formulate distribution strategies to match the potential PVR 
consumer segments to the sectors that can best serve them, adopting a total market model. 
8 
SURVEY INSTRUMENTS 
 
Specific survey instruments were designed for targeted respondents. Table 2 summarizes the survey 
tools and methodology used. 
 
 
a) Price-Tracking Survey: In this survey, adapted from the price-tracking survey manual 
designed by the World Health Organization (WHO) and Health Action International (HAI),9 
we tracked the real prices paid by women for family planning services/products in the 
three sectors: public, private nonprofit, and private commercial. This survey consisted of 
interviews with staff in facilities that were responsible for FP commodities management 
to get a snapshot of the pricing landscape of contraceptives currently sold in-country and 
to estimate the “Affordability” of the product and the “Ability to Pay” of potential PVR 
consumers to enable competitive pricing of the PVR. The respondents included those in 
charge of selected health facilities, including pharmacies and social-marketing outlets. A 
total of 62 health facilities were assessed in this survey, 17 from the private nonprofit 
sector and 45 from the private commercial sector. 
                                                                        
 
9 WHO/HAI: http://www.haiweb.org/medicineprices. 
 
FIGURE 1 THREE DIMENSIONS OF WTP FOR THE PVR—WILLINGNESS TO PAY, PROVIDE, 
AND PROCURE 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2   Study design, methodology, and scope 
Stakeholder Survey Instrument Target Respondents 
Consumers 
a) WT Pay Survey 
b) Price-Tracking 
Survey 
a) Potential consumers (women 18–49 years of age)  
b) Pharmacists; facilities in charge at social-
marketing outlets; public FP clinics 
Providers WT Provide Survey 
FP service providers and members of professional 
associations, such as pharmacists, ob/gyns, 
midwives, nurses, other providers 
Procurers WT Procure Survey 
MoH, UNFPA, USAID Mission, and large 
pharmaceutical distributors 
Consumers 
WT PAY 
PVR WTP 
Demand 
Procurers 
WT PROCURE 
Providers 
WT PROVIDE 
Availability and  
Access 
Service Delivery 
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b) WT Pay Survey (Consumer Survey): Consisted of interviews with potential PVR consumers 
directly to estimate the potential number of women who will pay a given price for the PVR 
and the characteristics of the individuals who will or will not pay that price. Exit interviews 
were conducted with women as they left facilities where FP services were offered. 
Respondents were shown a product sample and provided with a detailed description 
(use/benefits) of the PVR. Respondent interest was ascertained (by providing an option 
to rate their interest in the PVR before starting the survey) and uninterested respondents 
were not interviewed after recording the reason for their lack of interest. Questions 
focused on PVR pricing following a bidding game model based on the Contingent 
Valuation methodology as shown in Figure 3 (Foreit and Foreit 2001). Questions started 
with a modest PVR starter price, which was pegged at US$1.70 (N300) in all three 
sectors.10 The series of questions assume a 10% increase in price and subsequently a 
higher or lower increase based on the participant’s response. We ended the interview 
with two open-ended questions: (1) We asked about the maximum price the participant 
was willing to pay for the PVR independent of the previously mentioned prices; and (2) 
We sought to know the possible action the respondent would take if the price was found 
to be too high. Survey respondents included 400 urban and peri-urban women aged 18 
and above seeking family planning services at selected health facilities in Abuja. The 
number was distributed as follows: public (229); private nonprofit (80), and private 
commercial (91), following a stratified sampling strategy.  
c) WT Provide Survey: For providers, a “WT Provide Survey” was conducted. Family planning 
service providers in selected health facilities were aged 18 years and above. We 
interviewed a total of 50 providers—public (14), private nonprofit (3), and private 
commercial (33) sectors. The providers were asked qualitative questions to gauge their 
willingness to provide the PVR as part of the existing FP method mix in their health 
facilities. In addition, they were asked to estimate the maximum amount that should be 
charged (if any) for providing the PVR. Respondents included randomly selected FP 
providers such as gynecologists, nurses and matrons, pharmacists, and community 
health workers. 
d) WT Procure Survey: For the procurers, a “WT Procure Survey” was conducted and 
included representatives of government, and of social marketing and donor agencies 
involved in procuring FP commodities. A total of 19 procurers were interviewed.  
Procurers were asked to provide the price list of procured FP commodities and their 
assessment of a reasonable price estimate for procuring the PVR, to assess their 
willingness to procure it.  
                                                                        
 
10 US$1.70 (N300) is the mean price of 3-month injectable contraceptives in Nigeria; there are marginal variations in price within the private 
sector (nonprofit versus commercial). FP commodities in the public sector are free, but we still used the starter price to determine WTP as this 
would serve as a realistic starter price for a public-sector client if the product were not available in the public sector. 
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IMPLEMENTATION 
Ethics clearance: The Federal Capital Territory Health Research Ethics Committee (FCTHREC) granted 
ethical clearance for the study. Informed consent was obtained from all participants. Anonymity of 
participants and confidentiality of the information provided was ensured.  
Site selection: The Federal Capital Territory (FCT) of Abuja, Nigeria’s capital city, was selected for the 
surveys because it provides a fair representation of the key population groups. Public family-planning 
centers and service-delivery facilities run by nonprofit organizations within and around the federal 
capital were also selected. Last, private commercial facilities were selected based on the availability 
of skilled providers and clients’ volume at those facilities. 
Training of data collectors: Training followed a systematic process that ensured data collectors’ 
effectiveness during the actual fieldwork. In the first phase of this process, a cascaded training model 
was used to train data collectors on the survey process, data-collection instruments, and the ethical 
conduct of the study. Survey tools were pretested and suggested modifications were incorporated 
prior to study implementation. All the data collectors participating in the study had previous 
experience conducting surveys in this setting.  
 
FIGURE 2 CONSUMER SURVEY: BIDDING-GAME MODEL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: Foreit and Foreit. 2001. “Willingness to pay surveys for setting prices for reproductive health products and services: A user’s manual.” 
Frontiers in Reproductive Health, Population council, Policy Project, and Futures Group International. 
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Results 
PRICE-TRACKING SURVEY 
Intersectoral Price Comparisons 
Table 3 shows the median prices of 
various contraceptives in the private 
nonprofit versus private commercial 
sectors. Tracking prices across these 
sectors provides useful information for 
tailoring affordable pricing strategies 
for the PVR given its utility and 
comparative advantages. As FP 
commodities are free in Nigeria’s public 
facilities, this sector was not tracked. 
As shown in Table 3, injectable 
contraceptives (which are progestin-
only and administered every three 
months like the PVR) are sold at the 
median prices of US$2.70 (N438) and 
(US$1.30) N200 in the private commercial and private nonprofit sectors, respectively. EC pills have 
the highest median price of approximately US$27 (N4,300) in the private commercial sector, which 
may indicate how much women are willing to spend to prevent unintended pregnancies. The 
Levonorgestrel Intrauterine System (LNG-IUS) is typically very expensive (ranging from N1,000–
N8,000 or US$6–$50 if found in private clinics), but is mostly offered free of charge in private 
nonprofit outlets (with a minimal service fee of N1,000) through a donation from the International 
Contraceptive Access Foundation (ICAF). In general, median prices for contraceptive commodities are 
higher in the private commercial sector than the nonprofit sector, as should be expected. 
Method Availability by Sector  
A wide variety of contraceptives are available in the three sectors; injectables and pills are the most 
popular among consumers, next to male condoms. Across the three sectors, the injectable Noristerat 
and the emergency contraceptive pill Postinor 2 are the most popular brands. Other commonly 
available brands include Gold Circle (male condoms), Depo Provera (injectable), Copper T (IUD), 
Jadelle (implant), and combined oral contraceptives. Respondents indicated that stocks are 
replenished on a monthly basis for the most popular methods in their facilities. 
 
 
                                                                        
 
11 At the time of the survey, US$1 = N160. 
TABLE 3   Median prices of commonly available 
contraceptives by sector 11  
Contraceptive 
Private Nonprofit 
Sector (Naira) 
Private Commercial 
Sector (Naira) 
Injectables 200 438 
Male Condoms 188 315 
Female Condoms 300 — 
Combined Pills 300 100 
EC Pills 300 4,300 
Implanon (1 rod) 200 3,000 
Jadelle (2 rods) — 3,000 
Copper IUD 450 2,000 
LNG-IUS (Mirena®) 1,000 — 
— =  Price not available. 
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CONSUMER SURVEY 
Sector Demographics 
As depicted in Table 4, of the 400 consumers surveyed, 229, 80, and 91 were from the public, 
private nonprofit, and private commercial sectors, respectively. In all the sectors, the majority of 
respondents fell between the ages of 25 and 39 corresponding to the ages for peak fertility in 
Nigeria. Similarly, over 80% of the surveyed consumers completed secondary or college education, 
indicating a highly educated population of women. In this sample, the proportion of respondents who 
had no education was low whether they were in the public (0.9%) or private nonprofit (1.3%) sectors. 
The majority of the respondents have 1–3 children with 61%, 51%, and 58% of women from the 
public, private nonprofit, and private commercial sectors, respectively, falling in this category. About 
20% of respondents across the three sectors have no children, and 1.7% of women have more than 5 
children as compared to the total fertility rate (TFR) of 5.5 in the country (NPC and ICF International 
2014). Overall, the consumers who participated in this study are representative of the urban rich 
profile, with higher social status and presumably higher levels of ability to pay. 
Almost all of the respondents were either currently using a contraceptive method or intended to use 
one in the future. This may in part reflect the study design and the future contraceptive demand in 
the country, at least for women in urban and peri-urban settings where this study took place. 
TABLE 4    Sociodemographic characteristics of study participants by sector 
Variable Public Sector Private Nonprofit Sector Private Commercial Sector 
 N=229 % N=80 % N=91 % 
Age 
  15–19 6 3 0 0 1 1 
  20–24 31 14 3 4 9 10 
  25–29 67 29 27 34 27 30 
  30–34 54 24 25 31 25 28 
>35 71 31 23 28 27 29 
Education 
  Primary 19 8 3 4 5 27 
  Secondary 94 41 20 25 24 26 
  College 93 41 47 59 51 56 
  None 2 1 1 1 0 0 
Number of children 
  None 33 14 20 25 23 25 
  1–3 139 61 41 51 53 58 
  4–5 48 21 10 13 13 14 
  >5 6 3 1 1 1 1 
Marital status 
  Yes 213 93 68 85 76 84 
  No 15 7 11 14 15 17 
FP use/intent 
  Yes, currently use 83 36 21 26 25 28 
  Yes, intend to use in future 146 64 55 69 66 73 
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Socioeconomic Characteristics of Study Participants by Sector 
TABLE 5    Socioeconomic characteristics of study participants by sector 
Variable Public Sector Private Nonprofit Sector Private Commercial Sector 
 n=229 % n=80 % n=91 % 
Occupation 
  Housewife/not working 48 21 15 19 11 12 
  Retail 31 14 11 14 15 17 
  Wholesale trade 17 7 1 1 4 4 
  Agriculture/livestock 2 1 0 0 2 2 
  Private work 27 12 31 39 42 46 
  Government work 69 30 9 11 9 10 
  Manual work 17 7 6 8 2 2 
Partner’s Occupation 
  Not working 2 1 0 0 1 1 
  Retail 5 2 1 1 1 1 
  Wholesale trade 9 4 1 1 10 11 
  Agriculture/livestock 4 2 1 1 3 3 
  Private work 63 28 28 35 28 31 
  Government work 74 32 22 28 17 19 
  Manual work 28 12 6 8 5 6 
Household Items 
  Television 215 94 79 99 89 98 
  Refrigerator 169 74 70 88 74 81 
  Vehicle 115 50 45 56 39 43 
  Mobile 221 97 80 100 87 96 
  Radio 195 85 70 88 80 88 
Salon Visits 
  Weekly 53 23 17 21 15 17 
  Two weeks/biweekly 35 15 16 20 12 13 
  Monthly 103 45 38 48 49 54 
  Does not visit 29 13 7 9 8 9 
Monthly Income (Naira) 
  1,000–10,000 15 7 1 1 4 4 
  10,001–50,000 69 30 20 25 30 33 
  >50,000 69 30 29 36 29 32 
 No response/Does not know 76 33 30 38 28 31 
Monthly Expenses (Naira) 
  1,000–10,000 24 11 1 1 9 10 
  >10,000–50,000 95 42 29 36 31 34 
  >50,000 60 27 24 31 26 29 
No response/Does not know 50 22 26 33 25 28 
Monthly FP Expense (Naira) 
  1,000–10,000 9 4 1 1 2 2 
  >10,000–50,000 28 13 10 13 12 13 
  >50,000 7 7 4 4 6 6 
No response/Does not know 185 81 66 83 71 78 
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Table 5 depicts the socioeconomic characteristics of the respondents. More than 80% of the 
consumers surveyed were gainfully employed. This nearly mirrors the Nigeria Demographic and 
Health Survey 2013, which indicates that more than 70% of Nigerian women were employed, with 7 
out of 10 of the employed women able to make independent decisions on how they spend their 
earnings. The majority of the women reported household monthly incomes of between N10,000 
(US$63) and N100,000 (US$625), with about 16% reporting more than N100,000 per month. 
More than half of the women (59%) across the three sectors visit a hair salon on a monthly basis, 
whereas 20% visit on a weekly basis. Although most of the respondents did not disclose their monthly 
expenditure for family planning services, the high employment rate and the average monthly income 
of the respondents suggest a population with high purchasing power, increasing the potential for 
consumers to purchase the PVR. Across the three sectors, 13% of respondents indicated that they 
spent between N10,000 (approximately US$63) and N50,000 (approximately US$313) on their 
family planning needs. The frequency of hair salon visits among consumers in this study suggests the 
availability of discretionary income; however, the extent to which decisions on discretionary expenses 
are made will depend on the range of needs that women may have and the priority they give to 
reproductive health and FP services. 
WTP for the PVR by Level of Increments and Sector  
Table 6 shows that over 95% of respondents were interested in the PVR and participated in the 
bidding game. Consumers responded to hypothetical increases in the price of the PVR starting from a 
fixed price of N300 (approximately US$2), which is the median cost of injectable contraceptives that 
are also administered every three months. More than 89% of respondents surveyed in the public 
sector (195), 90% in the private nonprofit sector (70), and 94% in the private commercial sector (85) 
were willing to buy the PVR at the starting price. This shows that most women who use all the sectors 
are willing to purchase the commodity at a price comparable to the cost of injectable contraceptives, 
with increasing tendency to do so moving from the public to private commercial sector. The same 
pattern of higher willingness to pay in the private compared to the public sector continues with 
increases in the price of the PVR by 10% and 20%. For example, when the starter price was increased 
by 20%, although there was a decline in the willingness to pay across all the three sectors, those in 
the private nonprofit (74%) and private commercial (83%) sectors were more willing to purchase the 
PVR than those in the public sector (71%). 
For the PVR, over 85% of respondents interested in the method across the board indicated that they 
will pay an additional 5% over their maximum WTP amount if it would help widen FP access to women 
in low-resource settings. This altruistic willingness to pay is over 93% among respondents who access 
the private commercial sector for contraceptive services (as shown in Table 7). 
TABLE 6    WTP for the PVR by level of increments and sector 
Variable Public Sector (n=229) 
Private Nonprofit Sector 
(n=80) 
Private Commercial Sector 
(n=91) 
  %  %  % 
Respondents interested in PVR 218 95 78 98 90 99 
Starter price 195 89 70 90 85 94 
10% increment 170 78 64 82 80 89 
20% increment 154 71 58 74 75 83 
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Sector Demand Curve 
Figure 3 shows the PVR demand curve from the public sector consumers. In this sector, the 
willingness to pay for the PVR is plotted against a range of incremental hypothetical prices in order to 
gauge the value consumers place on the ring. It is clear that the demand falls with increasing price—
there is a considerable decline in WTP from N200 or US$1 (76%) to N300 or US$2 (31%) and it 
continues to fall until N600 or US$4 at which only 5% of the women were willing to pay for the ring. 
However, it is important to note that contraceptive commodities are free of charge in the public 
health system across Nigeria and this category of consumers are accustomed to receiving 
commodities free of charge. Given this knowledge, we can conservatively assert that consumers 
within the public sector place high value on the ring, as up to 76% of them would still have a demand 
for the ring at a price of N200 (US$1) which is equivalent to the price of a pound of onions in Abuja. 
 
 
TABLE 7    Altruistic WTP for the PVR by sector 
Altruistic WTP (WTP 5% over 
maximum stated amount if 
used to help other women) 
Public Sector Private Nonprofit Sector 
Private Commercial 
Sector 
 n=229 % n=80 % n=91 % 
Yes 195 85 70 87 85 93 
No 31 14 10 13 6 7 
Does not know 3 1 0 0 0 0 
 
 
FIGURE 3 CONSUMER DEMAND CURVE FOR PVR—PUBLIC SECTOR 
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In contrast, the demand curve for consumers who obtain services through the private nonprofit sector 
showed different demand outcomes, as depicted in Figure 4. In this case, at a price of N200, the 
demand for the PVR is still high at 90%. Thereafter, there is a sharp decline in the demand curve, with 
32% willing to pay for the ring at N500 (US$3). The demand curve for consumers who obtain their 
services from the private commercial sector is similar; demand for the PVR is at 93% when the price 
of the PVR is at N200 and declines thereafter (as shown in Figure 5).   
The inflection point in the demand curve occurs around the N600 for the private sectors, although 
there is robust demand at prices above that as well. For the public sector, the inflection point is at 
prices close to approximately N500. 
 
FIGURE 4 CONSUMER DEMAND CURVE FOR PVR—PRIVATE NONPROFIT SECTOR 
 
 
 
FIGURE 5 CONSUMER DEMAND CURVE FOR PVR—PRIVATE COMMERICAL SECTOR 
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In addition to analyzing the economic aspects of decision-making, we also examined other reasons 
why consumers would be willing to pay for the ring. Figure 6 displays the relative contributions of 
other determinants of demand across the public, private nonprofit, and private commercial sectors, 
respectively. As the figure depicts, the price of the ring is a very important consideration for 
consumers across all sectors, but the relative contribution of price progressively diminishes from the 
public to the private sector. For example, while 54% of public sector consumers would purchase the 
ring because the price is perceived to be affordable, fewer consumers in the private nonprofit (36%) 
and private commercial (37%) sectors, respectively, would make purchase decisions based on the 
price. 
The next important consideration in women’s demand for the ring is fear of the economic 
consequences of unintended pregnancy, leading to higher expenses. The relative value of this 
determinant varies from sector to sector. Fear of unintended pregnancy as a determinant of demand 
is highest among consumers in the private nonprofit sector (31%), followed by the private commercial 
sector (27%), and last, the public sector (24%). 
The next most important determinant as reported by consumers is the desire for an effective family 
planning method during the postpartum period, with 23%, 13%, and 12% of private nonprofit, private 
commercial, and public sector consumers, respectively, willing to pay for the ring on this account. 
(See Figure 6.) Other reasons include recommendations of health service providers and other 
nonspecific considerations. What this implies is that women, irrespective of where they receive their 
contraceptive services, are not motivated only by one factor such as the price of the method alone. 
The motivation for demand for a given product/service varies from one woman to another depending 
on the prevailing socioeconomic circumstances, but the price is an important general consideration. 
  
 
FIGURE 6 REASONS FOR WTP FOR THE PVR BY SECTOR 
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As the Council introduces the PVR in Nigeria, the experience and lessons learned from this process 
will be utilized to guide similar introductory efforts for another ring type, a long-acting combined 
hormonal vaginal ring developed for contraceptive protection outside the breastfeeding period. As 
shown in Table 8, over 95% of respondents, irrespective of sector, were interested in this ring. In the 
bidding game for this ring, consumers in the public (65%), private nonprofit (77%), and private 
commercial (75%) sectors expressed willingness to pay for this one-year CVR at the starter price. With 
price increases, although there is a decline in the willingness to pay, the demand is still high; for 
example, at a 20% increase over the starter price, 45% of public sector consumers and 55% of 
private sector consumers would still be willing to pay for the product.  
As can be seen in Figure 7, demand for the one-year CVR in the public sector remains high with 
incremental prices up to N1,000 or US$6 (68%). Even at N1,500 or US$9, 27% of the consumers 
expressed willingness to buy the one-year ring. In the private nonprofit sector, the demand stays high 
at 84% even at a price of N1,500 (Figure 8), while 81% of consumers in the private commercial 
sector would buy the one-year CVR at the same N1,500 (Figure 9). The analysis indicates that N1,000 
is the inflection point in the demand curves of all sectors for the investigational one-year CVR. It is 
clear that consumers are willing to pay for the one-year CVR at much higher prices than they would for 
the PVR. One reason for this preferential demand for the investigational one-year CVR at a much 
higher price could be the ring’s duration of action, which is one year as opposed to the PVR which 
lasts for three months. 
TABLE 8    WTP for the one-year CVR by level of increments and sector 
Variable Public Sector Private Nonprofit Sector Private Commercial Sector 
 n=229 % n=80 % n=91 % 
Starter price 145 65 60 77 66 75 
10% increment 119 54 52 67 55 63 
20% increment 98 45 43 55 48 55 
Respondents interested in PVR 219 96 78 98 88 97 
 
 
FIGURE 7 CONSUMER DEMAND CURVE FOR ONE-YEAR CVR—PUBLIC SECTOR 
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Consumers’ perception of the PVR is generally encouraging (Table 9). Many believe it is a good 
innovation for breastfeeding women who want to use a modern method of contraception for spacing. 
Many would recommend it to others because they perceive that it has little or no side effects. 
However, some women feel that the PVR is invasive because of its vaginal use and others feel that 
the size of the PVR is unappealing. It is to be noted that responses on size and shape are typical 
when respondents are asked about perceptions without having had any experience using the ring.12  
  
                                                                        
 
12 Women who had used the ring for another study reported that size, color, and texture were not important determinants; with 
use, responses on all of these three attributes improved over time. 
 
FIGURE 8 CONSUMER DEMAND FOR ONE-YEAR CVR—PRIVATE NONPROFIT SECTOR 
 
 
 
 
 
FIGURE 9 CONSUMER DEMAND FOR ONE-YEAR CVR—PRIVATE COMMERCIAL SECTOR 
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TABLE 9   Consumer comments on PVR and one-year CVR by sector 
Sector Comments on PVR Comments on One-Year CVR 
Public “The product is okay/good. It is affordable.”   
“It is easy to use.”  
“I am skeptical about the product.”  
“Maintain the quality of the product.”  
“Make it good, effective, or improve the quality (size, 
packaging, duration).” 
“Product is okay. Make it available.”  
“It is easy to use.” 
“I like the product. I recommend it to women.”  
“Prefer other products. Will give it a trial, because 
of duration (of use).” 
Private 
Nonprofit 
“The product is good.” 
“Make it affordable.” 
“Make it available.”  
“I am willing to buy it.” 
“Product is okay/good.” 
“Make it affordable.”  
“Maintain the quality of the product. I like the 
product and will recommend it to women.” 
Private 
Commercial 
“Make it easy to use and provide assistance for use.”  
“It is invasive.”  
“It is safe, with little or no side effects.” 
“I like the product. I will recommend it to women.” 
“There is a need to create more awareness 
among women.” 
 
PROVIDER SURVEY 
Provider Profile by Sector 
 
  
TABLE 10   Provider profile by sector 
Sector Profile (Job Titles, Education, Responsibilities Regarding Family Planning) 
Public Job titles: CHEWs/CHOs; gynecologists; managers; matrons, nurses 
Education: Secondary/College/Graduate; Specialists  
Responsibilities regarding FP: Consultation on FP information; counseling and servicing on FP methods; 
counseling and guidance; teaching about FP 
Private 
Nonprofit 
Job title: CHEWs; CHOs; nurses  
Education: College  
Responsibilities regarding FP: FP Counseling; provide FP commodity to clients 
Private 
Commercial  
Job title: Administrative officers; attendants; auxiliary nurses; CHEWs; laboratory attendants; laboratory 
technicians; medical directors, medical officers, managers; matrons, nurses, midwives; pharmacists; 
resident doctors; sales representatives 
Education: Secondary/College/Graduate  
Responsibilities regarding FP: Counseling and dispensing; counseling and treatment; counseling and 
administering drugs; selling contraceptive commodities; creating awareness about FP; help clients make the 
right method choices; conduct deliveries; provide FP information and services 
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A range of providers was interviewed across all sectors. All interviewed providers were involved in 
some aspect of family planning service delivery, including counseling, commodity provision, 
education, and administration (Table 10). Providers ranged from gynecologists and obstetricians, to 
nurses/midwives, Community Health Extension Workers (CHEWs), Community Health Officers (CHOs), 
and other administrative and supportive staff. Although there are more gynecologists in the public 
sector than in other sectors, every sector has the necessary mix of skilled personnel to provide the 
range of methods available in the country. 
 
Sector Qualitative Comments 
As was the case with clients’ perceptions, providers also expressed feelings about the PVR and the 
one-year CVR (Table 11). While the majority of comments on the rings were positive, some expressed 
reservations. For example, while many providers felt that self-use and easy reversibility of the method 
were positive features, they also reported concerns about the “big size” and the ring’s potential for 
interfering with intercourse. As found in other studies, most of these negative perceptions would likely 
fade away after the rings are introduced and used. However, as first impression matters, education 
and support for family planning providers is essential during the introductory phase. Suffice to say 
that vaginal rings should be introduced in phases, starting with providers at urban and peri-urban 
public facilities, and gradually scaling up to the urban private sector.  
  
TABLE 11   Provider comments on the PVR and one-year CVR by sector 
Sector Comments on PVR Comments on One-Year CVR 
Public “It is a welcome development.” 
“It will be easy to use, prevent taking daily pill.”  
“The price should be subsidized in rural areas.”  
“The size of the ring is too big.” 
“I am looking forward to seeing the long-acting 
ring.”  
“This will be good as it is for all women.”  
“It will replace vaginal cap (not in stock).” 
Private 
Nonprofit 
“Good for spacing, if it works as said.”  
“Training of health workers should be done.” 
“We will like it if there is training.” 
Private 
Commercial 
“Reduce the size to make it comfortable.”  
“I am concerned about its reliability.” 
“It is good and convenient if tested and proven.” 
“It is hard and big, may scare the users.”  
“It will need demonstration for usage.”  
“It is big to stay at posterior fornix of the vagina.” 
“I will appreciate it with affordable price.”  
“It gives opportunity to try new FP method.” 
“I like the idea of self-administration.” 
“Its longevity (one year) will be a better idea.”  
“It will likely interfere with intercourse.” 
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PROCURER SURVEY 
Procurer Profile by Sector 
A wide range of procurers were interviewed including policymakers, regulators, representatives of 
local and international nongovernmental organizations, community stakeholders, social franchising 
organizations, civil societies, local and international donors, and representatives of government 
agencies. Across both the public and private sector, all registered contraceptive commodities in 
Nigeria are being procured and distributed (Table 12). 
  
TABLE 12   Provider profile by sector 
Sector Profile (Job Titles, Responsibilities, Names of Organizations, Products Procured) 
Public Job titles: Chief pharmacist; chief regulatory officer; clinician; director of pharmaceutical services; logistics 
officer; logistics manager 
Responsibilities regarding FP: Daily stock-taking of RH commodities and ensuring that commodities are 
available; logistic officer in charge of procurement and management; provision of FP services to clients; 
regulation and registration of FP devices; stock management and reporting and distribution to states; 
supervising and coordinating product regulation at NAFDAC 
Name of organizations: National Essential Drugs programs; Catholic Relief Services; FMoH; NAFDAC; 
National Hospital Abuja 
Products procured:  Male condoms; IUDs; combined oral contraceptives; implants; EC pills; CycleBeads 
Private Non-
Profit 
Job titles: Nursing officers/midwives, assistant managers, clinical director; clinical service manager; country 
director DKT; director of procurement; enterprise fund manager; logistics advisor; logistics and commodity 
program manager; national coordinator, CiSFP; program officer for service delivery; program officer for 
advocacy; state coordinator, CiSFP; RH coordinator, CRS; national program specialist, FP 
Responsibilities regarding FP: Advising the government and providing technical support for quantification; 
coordinating FP services for the states; distributing LNG-IUS to FP service facilities; quality assurance and 
monitoring; FP needs identification and requisition for communities; advocating for FP interventions with 
local and international organizations; marketing and distribution of contraceptive products; social marketing 
for FP commodities; stock management and requisition; supporting quantification and supply-chain 
procedures for the government; galvanizing actions with civil society organizations to support FP 
Name of organizations: CiSFP; CRS; DKT International; FHI 360; JSI; Marie Stopes–Nigeria; MSI; PPFA; 
Rotary Club; SFH; UNFPA; USAID 
Products procured: Female condoms; implants; LNG-IUS; male condoms; EC pills; implants; injectables; 
combined oral contraceptives; IUDs; Sayana Press; CycleBeads 
Private 
Commercial  
Job titles: Pharmacist; pharmacy manager; supplementary pharmacist 
Responsibilities regarding FP: Dispensing and referring couples for FP services; introducing available FP 
methods to clients and counseling on method-administration processes 
Name of organizations: Anijah Pharmacy; Bez Pharmacy and Stores Nigeria; Indumex Pharmacy; Rabina 
Pharmacy 
Product procured: Condoms; EC pills; injectables; combined oral contraceptives 
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Procurer Priorities (Process, Quality Control, Logistics) by Sector 
Nigeria has a robust system in place for contraceptive procurement, pricing, and quality control 
across the public, private nonprofit, and private commercial sectors (Table 13). Because UNFPA 
procures commodities for the public system, pricing and quality control are done according to 
international standards. The processes for the private nonprofit system are based on the World 
Health Organization (WHO) standard and pricing is done through a very competitive process. The 
private commercial sector predominantly relies on a supply and verification system of social 
franchising organizations such as SFH and DKT International. Even though robust mechanisms and 
processes are in place, there are often reported cases of substandard and counterfeited reproductive 
health and FP commodities, highlighting the importance of continuous vigilance. 
  
TABLE 13    Procurer priorities by sector 
Domain Public Sector Private Nonprofit Sector Private Commercial Sector 
Procurement 
Process 
“My boss does the 
quantification, forecasting, and 
planning before mandating to 
UNFPA who procures the 
commodities. Procurement is 
made by direct purchase from 
the manufacturers.” 
“We used a form supplied from 
London to enable us do forecasting 
based on usage rate.”  
“We also use ‘basket fund’ for 
procurement, which is donor-
contributed.” 
“JSI supports, coordinates, 
requests from state offices, and 
places order (for procurement) 
from the manufacturers, while DKT 
International procures directly from 
the manufacturers.” 
“Purchases are made from Society for 
Family Health or DKT International and 
wholesalers through a third-party 
agreement.” 
Price Setting “It is mainly based on the 
supplier’s quotation. 
Manufacturers set prices, which 
are then negotiated. UNFPA 
handles the negotiation with the 
manufacturers.” 
“We ask for a quotation from 
vendors at the central and national 
level. Based on negotiation with 
the manufacturers and in check 
with other social-marketing 
organizations such as DKT and the 
prevailing market situation, we 
send a tender through a 
competitive process.” 
“Prices are set by producers and agents. 
We do not set prices.” 
Quality Control “It is done in collaboration with 
NAFDAC and complying with 
WHO PQ, and determined 
through the Essential Medicines 
List (EML) committee. The quality 
specification can be found in the 
EML. We test the product based 
on the manufacturers’ 
instruction.” 
“It is based on WHO PQ and EML of 
Nigeria. Company preshipment 
assessment is conducted following 
WHO guidelines. NAFDAC also 
inspects and regulates on arrival. 
Organizations have their own 
guidelines that are drafted and 
adopted from WHO guidelines. So, 
quality control is done by the 
manufacturers, local regulator, and 
procuring organizations.  
“We check for expiration dates and only 
the drugs on the EML are included. We 
also rely on the reputation of suppliers, 
e.g. SFH and DKT, and on 
recommendations of agents or 
manufacturers.” 
NAFDAC = National Agency for Food and Drug Administration and Control. PQ = Prequalification.  
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TABLE 14   Procurer comments on the PVR and one-year CVR by sector 
Sector Comments on PVR Comments on One-Year CVR 
Public “Good method for breastfeeding women.”  
“It has to be registered first. Some women would use it. 
This will promote healthy child spacing.” 
“It will add to the available methods mix.”  
“It will prevent unwanted pregnancies and 
reduce illegal abortion. With this, most ladies 
can complete their education.” 
Private 
Nonprofit 
“It [procurement and use] depends on the government. The 
government determines what is procured.”  
“If it is really as you have described it, it looks as if it would 
be liked by most spouses.” 
“[For procurement and availability], it is the 
same with the PVR: It depends on government 
(willingness). It will help bring down the cases 
of unwanted pregnancies.” 
Private 
Commercial 
“If the public likes and asks for it, and it is not complicated 
… it will certainly be of high demand for child spacing.” 
“Girls would like and use it. It will help our 
women. Removal at users’ convenience; 
women will like it.” 
 
Procurers are unanimous on the utility and value-adding potential of the PVR and the one-year CVR 
when eventually registered and introduced in the country (Table 14). The rings would add to the mix 
of contraceptive methods in the country and are generally perceived as capable of improving the 
uptake of contraceptives (Ross and Stover 2013) and thus preventing unwanted pregnancies and 
enhancing healthy child spacing. However, for this to happen, according to the views of many 
procurers, the government should show interest by playing a leading role in contraceptive 
procurement and distribution. 
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Conclusion 
Contraceptive services and commodities are available free of charge at public health facilities in 
Nigeria. However, public facilities have frequent stock-outs and hence the private sector accounts for 
more than 60% of contraceptive provision in the country in both rural and urban settings. The 
government of Nigeria has committed to a goal of reaching a CPR of 36% by 2018 and has outlined 
an ambitious strategy for achieving this goal. The introduction of new contraceptives to enhance 
contraceptive choice and address unmet need for family planning is part of the strategy. However, 
new product introduction often suffers from a lack of available market research and relies on 
hypothetical approaches to gauge consumer demand. As a new product in sub-Saharan Africa, similar 
challenges will be faced by the PVR. To prepare for and facilitate eventual introduction into Nigeria, 
we undertook this study to assess consumers’ “Willingness to Pay,” providers’ “Willingness to 
Provide,” and procurers’ “Willingness to Procure.” Findings were generated on all three aspects and 
are listed below.   
 Prospective consumers, providers, and procurers expressed support and interest in 
contraceptive vaginal rings. Frequently expressed opinions were that the PVR (and the one-
year CVR) is a welcome development that would add value to the postpartum family planning 
landscape, broaden contraceptive options for women, enhance child spacing, and prevent 
unintended pregnancies. 
 Consumers are willing to pay for the PVR irrespective of the sector through which they access 
contraceptive commodities. At a price point of US$1.7 (N300), more than 75% of consumers 
are willing to pay for the PVR in the public, private nonprofit, and private commercial sectors. 
Willingness to pay in the public sector declines at prices over N300. However, in the private 
sector (nonprofit and commercial), a significant proportion of women are willing to purchase 
the PVR at higher prices.   
 Although the price of the PVR is a determinant of consumer demand, respondents also 
indicated other factors such as the desire to avoid unintended pregnancy and the ability to 
use modern contraceptives as being important to their decision-making. The importance of 
wanting to avoid unwanted pregnancy is clearly reflected in the market as evidenced by the 
high median cost of EC pills (US$27) in the private sector.   
 Consumers are willing to pay for the one-year CVR as well. The analysis indicates a feasible 
price point of US$9 (N1,000) with a demonstrated willingness to pay across all three sectors. 
At this price, more than 65% are willing to pay in the public sector and more than 80% in the 
private nonprofit and commercial sectors.   
 The potential for innovative pricing mechanisms, especially for public-sector consumers will 
need to be explored. The mechanism would leverage existing government subsidies so that 
consumers pay a small portion of the price with financing covering the rest.  
 The active role of the private sector in FP provision is indicative of the possibility of utilizing a 
vibrant total market for the introduction of the PVR to serve its customer segments based on 
their levels of willingness to pay.  
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 Providers across all three sectors indicated the importance of including the PVR and one-year 
CVR in the method mix. Their responses also highlighted the importance of orientation and 
education for potential providers to ensure successful integration of the rings when 
eventually registered.  
 The procurement, pricing, and quality-assurance systems are robust in Nigeria. The PVR (and 
the one-year CVR), when introduced, could easily feed into the existing structures and obviate 
the need for establishing parallel procurement, pricing, and quality-assurance systems. 
Through this study we have gained better insight into the socioeconomic determinants of product 
use, including the consumer’s willingness to pay and also the priorities that drive the important 
stakeholders—providers and procurers. In terms of utilization, the results generated will inform and 
guide next steps about product introduction. Specifically, the findings of this study will be integrated 
with results from a market-segmentation exercise conducted earlier to develop a pricing model for 
the PVR. The price will reflect not only the cost of goods and cost of product introduction (training, 
educational material, marketing and branding, demand creation), but also the benefits to the health 
system (e.g., limited need for infrastructure and equipment, potential for multiple service outlets and 
health cadres). The results will also be useful to refine PVR market segmentation and tailor specific 
strategies for product introduction, including innovative financing approaches.  
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